Company / Shareholders' Equity
Eton Pharmaceuticals, Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$24.4M
FY2025
5-year range
$10.6M / $24.4M
FY2021-FY2025
Trend
+86.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 7 years, ranging from -$7M in FY2019 to $26M in FY2020.
Based on SEC 10-K filings.
$24M in FY2025 with a 5-year CAGR of -1.5%.
Improved from $16M to $24M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- -1.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.5%, indicating a declining trend.
- In FY2025, shareholders' equity increased 86.8% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.4M | +86.8% |
| FY2024 | $13.1M | -16.5% |
| FY2023 | $15.7M | +0.0% |
| FY2022 | $15.7M | +48.5% |
| FY2021 | $10.6M | -59.9% |
| FY2020 | $26.3M | +482.6% |
| FY2019 | -$6.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026